Not all of the dangerous, controversial drugs are banned in baseball

64 Comments

We get up in arms about testosterone and HGH — substances our bodies naturally produce and which have few serious side effects or long-lasting consequences — because they’re on a banned list. Meanwhile there’s a drug that a lot of athletes take under the direction and supervision of their teams which can kill people and is banned in several countries: the anti-inflammatory Toradol.

Gordon Edes of ESPN Boston has a story about its use in baseball. The hook: an interview with Jonathan Papelbon who took it routinely when he was with the Red Sox but who was told by the Phillies that he can no longer take it as they do not allow it.  Edes looks into the controversial drug, notes its serious side effects, which can include internal bleeding (Clay Buchholz believes it’s what led to him contracting esophagitis which landed him in the ICU) and notes that it’s banned in several countries, for athletes and normal folks alike.

Papelbon’s description of its use in Major League Baseball is pretty familiar-sounding: it’s taken before the game to help guys “get through a 162 game season.” It’s, by definition, a performance enhancing drug. It’s letting guys do things they otherwise couldn’t do. Allowing their bodies to recover faster which allows them to train harder and compete at a more intense level than they otherwise could. Except it’s not on a banned list so no one cares despite the fact that it has the potential to kill you.

There is a tremendous disconnect between the drugs people think are awful in sports and the drugs that truly have the potential to be harmful. This is maybe the best example. Might be nice if we thought about our priorities about these things once in a while.

Bradley Zimmer to miss 8-12 months after shoulder surgery

Cleveland Indians v Minnesota Twins
Getty Images
1 Comment

Indians outfielder Bradley Zimmer is out for the year after undergoing arthroscopic surgery on his right shoulder, the team announced Saturday. The projected recovery timetable spans anywhere from 8-12 months, which puts Zimmer’s return in the second half of the 2019 season, assuming that all goes well.

Zimmer, 25, had not made an appearance for the Indians since June 3. He racked up a cumulative nine weeks on the major- and minor-league disabled lists this season and will have finished his year with a .226/.281/.330 batting line, seven extra-base hits, and four stolen bases in 114 plate appearances.

The outfielder reportedly sustained his season-ending injury during a workout in Triple-A Columbus, where Cleveland.com’s Joe Noga says Zimmer began feeling discomfort in his shoulder after completing a set of one-handed throwing drills. Comments from club manager Terry Francona suggest that the Indians have every reason to believe that he’ll make a full recovery by next summer, though it’s not yet clear whether or not he’ll need additional time to readjust to a full workload when he takes the field again.